Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapy. - Chuang SH; Lee YE; Huang LYL; Chen CK; Lai CL; Lin YH; Yang JY; Yang SC; Chang LH; Chen CH; Liu CW; Lin HS; et al. (European journal of medicinal chemistry, 2020)